Announcement

Collapse
No announcement yet.

Takeda selling Xiidra to Novartis

Collapse
X
  •  
  • Filter
  • Time
  • Show
Clear All
new posts

  • Takeda selling Xiidra to Novartis

    I think this sales may enable Xiidra to be sold in Europe
    "Takeda Pharmaceutical has entered into an agreement to sell Xiidra to Novartis for up to $5.3 billion.


    The sale will enable Takeda to focus on its key business areas of gastroenterology, rare diseases, plasma-derived therapies, oncology and neuroscience, according to a company press release.

    Xiidra (lifitegrast ophthalmic solution 5%) is the only prescription treatment approved by the FDA for signs and symptoms of dry eye disease.

    Takeda will receive $3.4 billion upfront in cash and up to an additional $1.9 billion in milestone payments from Novartis, the release said.

    In addition, Takeda will sell the TachoSil fibrin sealant patch to Ethicon for approximately $400 million upfront in cash."

    https://www.healio.com/ophthalmology...=2404801039954


  • #2
    Finally! I hope it will be marketed in Europe as soon as possible.

    Comment

    Previously entered content was automatically saved. Restore or Discard.
    Auto-Saved
    Smile :) Biggrin :D Wink ;) Rolleyes :rolleyes: Tongue :p Cool :cool: Redface :o Confused :confused: Eek :eek: Frown :( Mad :mad:
    x
    Insert: Thumbnail Small Medium Large Fullsize Remove  
    x
    Working...
    X

    Debug Information